Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - BLUE BIOFUELS, INC. | Financial_Report.xls |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(First Amendment)
Annual Report Pursuant to Section 13 or 15(D) of the Securities Exchange Act of 1934
for the fiscal year ended December 31, 2014
Transition Report Under Section 13 or 15(D) of the Securities Exchange Act of 1934
for the transition period from _______________ to _______________
Commission File Number: 333-181633
ALLIANCE BIOENERGY PLUS, INC.
(Exact name of small Business Issuer as specified in its charter)
Nevada | 45-4944960 |
(State or other jurisdiction of incorporation or | (IRS Employer Identification No.) |
organization) |
|
|
|
400 N. Congress Avenue, Suite 130 |
|
West Palm Beach, FL | 33401 |
(Address of principal executive offices) | (Zip Code) |
Issuer's telephone number, including area code: (888) 607-3555
n/a
Former address if changed since last report
Securities registered under Section 12(b) of the Exchange
Act: None
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, par value $0.001 per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [X].
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Check if there is no disclosure of delinquent filers in response to Item 405 of Regulation S-K contained in this form, and no disclosure will be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large Accelerated Filer o |
| Accelerated Filer o |
| Non-Accelerated Filer o
|
| Smaller Reporting |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter (June 30, 2014): $13,162,746
State the number of shares outstanding of the registrant's $.001 par value common stock as of the close of business on the latest practicable date (April 14, 2015): 37,718,225
Documents incorporated by reference: None.
Explanatory Note
The purpose of this Amendment No. 1 to Alliance BioEnergy Plus, Inc.’s Annual Report on Form 10-K for the fiscal year ending December 31, 2014 (the “Form 10-K”), as filed with the Securities and Exchange Commission on April 14, 2015, is to furnish Exhibits 101 to the Form 10-K in accordance with Rule 201(c) and Rule 405 of Regulation S-T. Exhibits 101 provide the financial statements and related notes from the Form 10-K formatted in XBRL (eXtensible Business Reporting Language). This Amendment No. 1 to the Form 10-K also updates the Exhibit Index to reflect the furnishing of Exhibits 101.
No other changes have been made to the Form 10-K. This Amendment No. 1 to the Form 10-K continues to speak as of the original filing date of the Form 10-K, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way the disclosures made in the original Form 10-K.
Item 6. Exhibits.
Exhibit No. |
| Description |
| Filed Herewith |
|
|
|
|
|
31.1 |
| Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| * |
|
|
|
|
|
31.2 |
| Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| * |
|
|
|
|
|
32.1 |
| Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| * |
|
|
|
|
|
101.INS † |
| XBRL Instance Document |
| X |
101 SCH † |
| XBRL Taxonomy Extension Schema Document |
| X |
101.CAL † |
| XBRL Taxonomy Extension Calculation Linkbase Document |
| X |
101 LAB † |
| XBRL Extension Labels Linkbase Document |
| X |
101.PRE † |
| XBRL Taxonomy Extension Presentation Linkbase Document |
| X |
101.DEF † |
| XBRL Taxonomy Extension Definition Linkbase Document |
| X |
* X † | Filed as an exhibit to the original Form 10-K for the fiscal year ended December 31, 2014, filed April 14, 2015. Filed herewith In accordance with SEC rules, this interactive data file is deemed “furnished” and not “filed” for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities and Exchange Act of 1934, and otherwise is not subject to liability under those sections or acts. |
|
|
SIGNATURES
In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
|
|
|
| ALLIANCE BIOENERGY PLUS. | |
| | |
Date: April 15, 2015 | By: | /s/ Daniel de Liege |
| _____________________________ Daniel de Liege. | |
| President | |